# Evaluation of Long Haul COVID-19 and Vaccine Immunogenicity in Patients With Liver Disease

> **NCT05107271** · — · COMPLETED · sponsor: **Post Graduate Institute of Medical Education and Research, Chandigarh** · enrollment: 252 (actual)

## Conditions studied

- COVID-19
- Chronic Liver Failure
- Cirrhosis, Liver
- Portal Hypertension
- Liver Transplant Disorder

## Interventions

- **DIAGNOSTIC_TEST:** COVID-19 serosurvey

## Key facts

- **NCT ID:** NCT05107271
- **Lead sponsor:** Post Graduate Institute of Medical Education and Research, Chandigarh
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-11-15
- **Primary completion:** 2022-12-15
- **Final completion:** 2024-03-15
- **Target enrollment:** 252 (ACTUAL)
- **Last updated:** 2025-06-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05107271

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05107271, "Evaluation of Long Haul COVID-19 and Vaccine Immunogenicity in Patients With Liver Disease". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT05107271. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
